Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: uniqure pharma inc. - amino acids , multivitamins , minerals - capsule - formulation: each capsule contains: iron (equivalent to 150 mg ferrous fumarate)-49.5mg zinc sulfate-50mg ascorbic acid (vitamin c)-40mg l-lysine hydrochloride-25mg glycine-10mg thiamine mononitrate (vitamin b1)-5mg l-histidine hydrochloride h2o-4mg riboflavin (vitamin b2)-3mg pyridoxine hydrochloride (vitamin b6)-1.5mg folic acid (vitamin b9)-500 mcg cyanocobalamin (vitamin b12)-2.5mg

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: medethix, inc; distributor: uniqure pharma inc. - rocuronium bromide - solution for injection (iv) - 10 mg/ml (50 mg/5 ml)

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: uniqure pharma inc. - 5% amino acids , 5% sorbitol - solution for intravenous infusion for injection - formulation: each 100 ml contains: glycerine l-phenylalanine l-arginine hydrochloride l-leucine l-lysine hydrochloride l-valine l-isoleucine l-aspartic acid l-histidine hci, h2o l-threonine 225 mg 200 mg 100 mg 100 mg 90 mg 760 mg l-methionine 533 mg l-alanine 500 mg l-proline 490 mg l-serine 430 mg l-tryptophan 360 mg l-glutamic acid 352 mg l-tyrosine 250 mg l-cysteine hci 250 mg sorbitol 250 mg 75 mg 25 mg 10 mg 5 mg this cpr is granted following a.0.31 s. 2005.

Philippines - English - FDA (Food And Drug Administration)

uniqure pharma, inc.; distributor: medethix, inc. - carmellose sodium - ophthalmic solution (eye drops) - 1.0% w/v (10 mg/ml)

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: vivilon pharmaceuticals inc. - amino acids , multiviatmins , minerals - capsule - formulation: each capsule contains: l-lysine- 25 mg folic acid (vitamin b9)-500mcg glycine- 10 mg cyanocobalamin (vitamin b12)-2.5mcg l-histidine hci h2o -4 mg ascorbic acid (vitamin c)-40mg thiamine mononitrate (vitamin b1)- 5 mg iron (equivalent to 150 mg ferrous fumarate) - 49.5mg riboflavin (vitamin b2)-3 mg zinc sulfate-50mg pyridoxine hcl (vitamin b6) 1.5 mg

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: i.e. medica, inc. - amino acids , multiviatmins , minerals - capsule - formulation: each capsule contains: l-lysine- 25 mg folic acid (vitamin b9)-500mcg glycine- 10 mg cyanocobalamin (vitamin b12)-2.5mcg l-histidine hci h2o -4 mg ascorbic acid (vitamin c)-40mg thiamine mononitrate (vitamin b1)- 5 mg iron (equivalent to 150 mg ferrous fumarate) - 49.5mg riboflavin (vitamin b2)-3 mg zinc sulfate-50mg pyridoxine hcl (vitamin b6) 1.5 mg

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: pharmacom distribution - amino acids , multiviatmins , minerals - capsule - formulation: each capsule contains: iron (equivalent to 150 mg ferrous fumarate)-49.5mg zinc sulfate-50mg ascorbic acid (vitamin c)-40mg l-lysine hydrochloride-25mg glycine-10mg thiamine mononitrate (vitamin b1)-5mg l-histidine hydrochloride h2o-4mg riboflavin (vitamin b2)-3mg pyridoxine hydrochloride (vitamin b6) 1.5 mg folic acid (vitamin b9) 500mcg cyanocobalamin (vitamin b12)-2.5mcg

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: vivilon pharmaceuticals inc - clindamycin (as phosphate) - solution for injection (im/iv) - 150 mg/ml

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: getz pharma (phils.) inc. - esomeprazole (as magnesium) - delayed release tablet - 40mg - anti-ulcerant - for short term treatment of gerd with erosive esophagitis in adults and pediatric patients 1 month to 17 years, inclusively as an alternative to oral therapy when oral esomeprazole is not possible or appropriate.

Philippines - English - FDA (Food And Drug Administration)

medethix, inc.; distributor: getz pharma (phils.) inc. - esomeprazole (as sodium) - lyophilized powder for iv injection/infusion - 40 mg - anti-ulcerant - for short term treatment of gerd with erosive esophagitis in adults and pediatric patients 1 month to 17 years, inclusively as an alternative to oral therapy when oral esomeprazole is not possible or appropriate.